NCT04948437View on ClinicalTrials.gov

Urinary Exosomal Biomarkers of Thyroglobulin and Galectin-3 for Prognosis and Follow-up in Patients of Thyroid Cancer

RecruitingOBSERVATIONAL

Enrollment

103

Participants

Timeline

Start Date

August 19, 2021

Primary Completion Date

October 31, 2024

Study Completion Date

October 31, 2026

Conditions

Thyroid CancerPapillary Thyroid CancerFollicular Thyroid Cancer

Trial Locations (1)

Unknown

RECRUITING

Chih-Yuan Wang, M.D, Taipei

All Listed Sponsors

lead

National Taiwan University Hospital

OTHER